The management of VTEC O157 infection

International Journal of Food Microbiology

Volumn 66, Issue 1-2, 2001, Pages 103-110

  Todd, W T A ^a   Dundas, S ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

Author keywords

Clinical management; HUS TTP; Risk factors; VTEC O157 infection

Indexed keywords

BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOKINE; FOSFOMYCIN; SHIGA TOXIN; TETRACYCLINE; VEROTOXIN;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; CONFERENCE PAPER; DIARRHEA; ESCHERICHIA COLI O157; FOOD POISONING; GRAM NEGATIVE INFECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKOCYTE COUNT; MORTALITY; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GREAT BRITAIN; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS; VIRULENCE;

PURPURA;

EID: 0035926960     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(00)00527-4     Document Type: Conference Paper

References (48)

1. Armstrong G.D., Fodor E., Vanmaele R. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164(6):1991;1160-1167.
2. Bell B.P., Griffin P.M., Lozano P., Christie D.L., Kobayashi J.M., Tarr P.I. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics. 100:1997;e12.
3. Belongia E.A., Osterholm M.T., Sole J.T., Ammend D.A., Braun J.E., MacDonald K.L. Transmission of Escherichia coli O157:H7 infection in Minnesota child-care facilities. JAMA. 269:1993;883-888.
4. Carter A.O., Borczyk A.A., Carison J.A.K., Harvey B., Hockin J.C. A severe outbreak of Escherichia coli O157:H7 associated haemorrhagic colitis in a nursing home. New Engl. J. Med. 24:1987;1496-1500.
5. Chapman P.A., Siddons C.A., Malo A.T.C., Harkins M.A. A 1-year study of Escherichia coli O157 in cattle, sheep, pigs and poultry. Epidemiol. Infect. 119:1997;245-250.
6. Cimolai N., Carter J.E., Morrison B.J., Anderson J.D. Risk factors for the progression of Escherichia coli O15:H7 enteritis to the hemolytic uremic syndrome. J. Pediatr. 116:1990;589-592.
7. Coia J.E. Nosocomial and laboratory-acquired infection with Escherichia coli O157. J. Hosp. Infect. 40(2):1998;107-113. Oct.
8. Commun. Dis. Rep., 1999. VTEC O157 outbreak associated with a farm visitor centre in North Wales. CDR Wkly. 9 (26), 227-230 (Jun 25).
9. Dohi H., Nishida Y., Mizuno M., Shinkai M., Kobayashi T., Takeda T., Uzawa H., Kobayashi K. Synthesis of an artificial glycoconjugate polymer carrying Pk-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin. Bioorg. Med. Chem. 7(9):1999;2053-2062.
10. Drummond K. Haemolytic uraemic syndrome - then and now. New Engl. J. Med. 312:1985;116-118.
11. Duncan L., Carter A., Carison J., Borczyk A., Karmali M. Outbreak of gastrointestinal disease in Sarnia, Ontario. Ont. Dis. Surveill. Rep. 7:1986;604-610.
12. Dundas S., Murphy J., Soutar R.L., Jones G.A., Hutchinson S.J., Todd W.T.A. Effectiveness of therapeutic plasma exchange in the 1996 Lanakshire Escherichia coli O157:H7 outbreak. Lancet. 354:1999;1327-1330.
13. Dundas S., Todd W.T.A., Stewart A.I., Murdoch P.S., Chaudhuri A.K.R., Hutchinson S.J. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death in hospitalised cases. Clin. Infect. Dis. 2001;. accepted for publication.
14. Griffin P.M., Tauxe R.V. The epidemiology of infection caused by Escherichia coli O157:H7, other enterohaemorrhagic E. coli and the associated haemolytic-uraemic syndrome. Epidemiol. Rev. 13:1991;60-98.
15. Higami O., Nishimoto K., Kawamura T., Tsuruhara T., Isshiki G., Ookita A. Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak. Kansenshogaku Zasshi (J. Jpn. Assoc. Infect. Dis.). 72:1998;266-272.
16. Ito T., Akino E., Hiramatsu K. Evaluation of antibiotics used for enterohemorrhagic Esherichia coli O157 enteritis - effects of various antibiotics on extracellular release of verotoxin. Kansenshogaku Zasshi (J. Jpn. Assoc. Infect. Dis.). 71:1997;130-137.
17. Jackson S.G., Goodbrand R.B., Johnson R.P., Odorico V.G., Alves D., Rahn K., Wilson J.B., Welch M.K. Khakhria R Escherichia coli O157:H7 diarrhoea associated with well water and infected cattle on an Ontario farm. Epidemiol. Infect. 120(1):1998;17-20.
18. Karmali M., Steele B., Petric M., Lim C. Sporadic cases of hemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1:1983;619-620.
19. Kawamura N., Yamazaki T., Tamai Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr. Int. 41:1999;218-222.
20. Kimmitt P.T., Harwood C.R., Barer M.R. Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones. Lancet. 353:1999;1588-1589.
21. Laurence J. Pathological and therapeutic distinctions in HUS/TTP. Lancet. 355:2000;497.
22. Leen C., Nathwani D., Nye F., Todd W.T.A. The management of infective gastroenteritis in adults: a consensus statement by an expert panel convened by the British Society for the Study of Infection. J. Infect. 33:1996;143-152. (Principal Authors).
23. Lousi C.B., Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin I'3, and tumour necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:1991;4173-4179.
24. Mahan J.D., McAllister C., Karmali M. Verotoxin 1(VT-1) induction of apoptosis in human glomerular capillary endothelial cells (GCEC) in vitro is dependent on cytokines, cell confluence and cell cycle. J. Am. Soc. Nephrol. 7:1996;1161.
25. Mead P.S., Griffin P.M. Escherichia coli O157:H7. Lancet. 352:1998;1207-1212.
26. Michino H., Araki K., Minami S., Takaya S., Sakai N., Miyazaki M., Ono A., Yanagawa H. Massive outbreak of Escherichia coli O157:H7 infection in school children in Sakai City, Japan, associated with consumption of white radish sprouts. Am. J. Epidemiol. 150(8):1999;787-796. Oct. 15.
27. Milne L.M., Plom A., Strudley I., Pritchard G.C., Crooks R., Hall M., Duckworth G., Seng C., Susman M.D., Kearney J., Wiggins R.J., Moulsdale M., Cheasty T., Willshaw G.A. Escherichia coli O157 incident associated with a farm open to members of the public. Commun. Dis. Public Health. 2(1):1999;22-26.
28. Outbreak of Escherichia coli O157:H7 and Campylobacter among attendees of the Washington County Fair - New York. MMWR Morb. Mortal Wkly. Rep. 48(36):1999;803-805. Sep. 17.
29. Moake J.L., McPherson P.D. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am. J. Med. 87:1989;3-9N-3-15N.
30. Nataro J.P., Kaper J.B. Dairrhoeagenic Escherichia coli. Clin. Microbiol. Rev. 11:1998;142-201.
31. Pavia A.T., Nichols C.R., Green D.P., Tauxe R.V., Mottile S. Haemolytic uraemic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. J. Pediatr. 116:1990;544-551.
32. Proulx F., Turgoen J.P., Delage G., Lafleur L., Chicoine L. Randomised controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J. Paediatr. 121:1992;299-303.
33. Riley L.W., Remis R.S., Helgerson S.D. Haemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:1983;681-685.
34. Rowe P.C., Orrbine E., Lior H., Wells G.A., Yetisir E., Clulow M., McLaine P.N. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. J. Pediatr. 132:1998;777-782.
35. Ryan C., Tauxe R.V., Hose G. Escherichia coli O157:H7 diarrhoea in a nursing home: clinical epidemiological and pathological findings. J. Infect. Dis. 154:1986;631-637.
36. Slutsker L., Reis A., Greene K.D., Wells J.G.et al. Escherichia coli O157:H7 diarrhoea in the United States: clinical epidemiological features. Ann. Intern. Med. 126:1997;505-513.
37. Swerdlow D.L., Griffin P.M. Duration of faecal shedding of Escherichia coli O157:H7 among young children in daycare centres. Lancet. 349:1997;745-746.
38. Takeda T., Yoshino K., Uchida H., Ikeda N., Tanimura M. Early use of fosfomycin for Shiga toxin-producing Escherichia coli O157 infection reduces the risk of hemolytic uremic syndrome. Kaper J.B., O'Brien A.D. Escherichia coli O157:H7 and Other Shiga-Toxin Producing E. coli Strains. 1998;385-387 ASM Press, Washington, DC.
39. Takeda T., Yoshino K., Adachi E., Sato K., Yamagata K. In vitro assessment of a chemically synthetised Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2. Microbiol. Immunol. 43(4):1999;331-337.
40. Tilden J. Jr., Young W., McNamara A.M.et al. A new route of transmission for Escherichia coli: infection from dry fermented salami. Am. J. Public Health. 86:1996;1142-1145.
41. Todd W.T.A. Management of an outbreak of gastroenteritis. Armstrong D., Cohen J. Infectious Diseases. 1999;241.3-241.5 Mosby Harcourt Publications.
42. Trevana W.B., Willshaw G.A., Cheasty T., Domigue G., Wray C. Transmission of verocytotoxin-producing Escherichia coli O157 infection from farm animals to humans in Cornwall and West Devon. Commun. Dis. Public Health. 2:1999;263-268.
43. Upton P., Coia J.E. Outbreak of Escherichia coli O157 infection associated with pasteurised milk supply. Lancet. 334:1994;1015.
44. Van de Kar N.C.A.J., Monnens L.A.H. Hemolytic uremic syndrome in childhood. Bull. Clin. Haematol. 11:1998;498-507.
45. Voetsch A., Wojtkunski C., Swartz M., Mshar R., Lambert-Fair M.A., Farrar J.A., Glynn M.K., Slutsker L. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch. Intern. Med. 159(15):1999;1758-1764. Aug 9-23.
46. Walters M.S., Matthei I.U., Kay R., Dhillon M.J. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr. Nephrol. 3:1989;130-134.
47. Walterspeil J.N., Ashkenazi S., Morrow A.L., Cleary T.G. Effect of sub-inhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1. Infection. 20:1992;25-29.
48. Wong C.S., Jelacic S., Habeeb R.L., Watkins S.L., Tarr P.I. The risk of the Hemolytic-Uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New Engl. J. Med. 342:2000;1930.